Saturday, September 27, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Riley Exploration Permian Announces Quarterly Dividend and Upcoming Earnings Report

Elaine Mendonca by Elaine Mendonca
January 19, 2024
in Breaking News
0
Wind Farms: How Strategic Acquisitions Amplify the Impact of Green Energy Players
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Riley Exploration Permian (AMEX:REPX) has recently made an exciting announcement regarding their quarterly dividend. Set at an attractive rate of 36 cents per share, this dividend is sure to catch the attention of shareholders. The ex-dividend date has been scheduled for Wednesday, meaning that the stock will open on that day at a price that is 36 cents lower than usual.

To be eligible for this dividend payout, shareholders must own REPX shares by the end of Tuesday’s trading session. For each share owned, investors will receive a dividend of 36 cents. The dividend payout will take place on February 08, 2024, giving shareholders the opportunity to reinvest their earnings back into the stock or utilize the payment in any way they see fit.

As of the reference date of January 19, 2024, the current price of REPX stock stands at $22.30. With a dividend yield of 4.53%, this presents an appealing investment opportunity for those seeking stable returns. Additionally, investors can mark their calendars for the upcoming earnings report on March 06, 2024, which will provide further insight into the company’s financial performance.

For real-time updates on the stock price, investors can conveniently monitor it on various financial websites such as Benzinga, Yahoo Finance, MarketWatch, and CNBC. These platforms offer valuable information and analysis to help investors make informed decisions about their investments.

REPX Stock Performance Declines: Caution Advised for Potential Investors

On January 19, 2024, REPX stock experienced a decline in its performance. The price of REPX shares dropped by $0.58 since the market last closed, representing a decline of 2.60%. Furthermore, the stock opened at $22.40, which was $0.10 higher than its previous close. However, the overall downward trend suggests that this gain was short-lived. REPX is trading near the bottom of its 52-week range and below its 200-day simple moving average, indicating a potential lack of positive momentum in the stock. Investors should exercise caution when considering investing in REPX. It is important to conduct thorough research and analysis before making any investment decisions.

REPX Stock Performance on January 19, 2024: Mixed Bag of Revenue Growth and Income Decline – Analysis and Implications for Investors

Title: REPX Stock Performance on January 19, 2024: A Mixed Bag of Revenue Growth and Income Decline

Introduction

On January 19, 2024, REPX stock showcased a mixed performance in terms of its financials. While the total revenue witnessed a significant increase both annually and quarterly, the net income and earnings per share experienced a decline. This article will delve into the stock’s performance, highlighting the key metrics and their implications for investors.

Total Revenue Growth

REPX’s total revenue for the past year amounted to $321.74 million, reflecting a growth of 113.02% compared to the previous year. The total revenue increased by 8.39% since the last quarter, demonstrating a consistent growth trajectory.

Net Income Decline

REPX’s net income witnessed a decline. Over the past year, the company reported a net income of $118.01 million, representing an increase of 279.71% compared to the previous year. However, the net income declined by 73.85% since the last quarter, reaching $8.65 million.

Earnings per Share (EPS) Performance

REPX’s earnings per share (EPS) is a crucial metric that provides insights into the company’s profitability on a per-share basis. Over the past year, the EPS stood at $5.99, indicating an increase of 243.01% compared to the previous year. However, the EPS decreased by 73.85% since the last quarter, reaching $0.43.

Conclusion

REPX’s stock performance on January 19, 2024, showcased a mixed bag of revenue growth and income decline. While the company experienced a significant increase in total revenue both annually and quarterly, the net income and earnings per share witnessed a decline. Investors should carefully analyze these financial metrics to make informed decisions. Conducting further research and monitoring REPX’s financial performance will be crucial for investors looking to make sound investment decisions.

Tags: REPX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Telecommunications Industry Stock Exchange

Analyst Raises Price Target for Bandwidth Expects Significant Upside

Technology Artificial intelligence Markets and money

ServiceNow Stock A Compounded Growth Success Story

Banking Markets and money

MainStreet Bancshares Prepares for Quarterly Earnings Report

Recommended

Quanta Services Stock

Infrastructure Giant Quanta Services Powers Up With Strategic Acquisition

1 week ago
Opendoor Stock

Opendoor Shares Surge on Renewed Fed Rate Cut Expectations

3 weeks ago
Certara Stock

Can Certara’s Market Leadership in Biosimulation Spark a Stock Revival?

2 weeks ago
Biotechnology Market Capitalization

MaxCyte and Wugen Partner to Revolutionize Cancer Treatments

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Blackstone’s Strategic Expansion Across Multiple Fronts Signals Growth Phase

Wabtec Shares Surge on Historic $4.2 Billion Locomotive Deal

Wells Fargo Emerges from Regulatory Shadow as Growth Path Clears

Smurfit WestRock Shares Defy Strong Sales with Post-Merger Plunge

Harley-Davidson Shares Show Signs of a Turnaround

Rocket Lab’s Strategic Gambit: Growth Amidst Executive Share Sale

Trending

Ideaya Biosciences Stock
Analysis

Clinical Trial Success Fuels Optimism for Ideaya Biosciences

by Felix Baarz
September 27, 2025
0

The oncology-focused biotechnology firm Ideaya Biosciences is demonstrating remarkable momentum in the markets. A combination of encouraging...

U.S. Bancorp Stock

Is U.S. Bancorp Poised for a Major Breakout?

September 27, 2025
FedEx Stock

FedEx Shares Surge on Unexpected Quarterly Strength

September 27, 2025
Blackstone Stock

Blackstone’s Strategic Expansion Across Multiple Fronts Signals Growth Phase

September 27, 2025
Wabtec Stock

Wabtec Shares Surge on Historic $4.2 Billion Locomotive Deal

September 27, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Clinical Trial Success Fuels Optimism for Ideaya Biosciences
  • Is U.S. Bancorp Poised for a Major Breakout?
  • FedEx Shares Surge on Unexpected Quarterly Strength

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com